» Authors » Leon C Snyman

Leon C Snyman

Explore the profile of Leon C Snyman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 56
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van Rensburg E, Seopela L, Snyman L
Pregnancy Hypertens . 2024 Sep; 38:101155. PMID: 39243692
Objectives: To investigate the relationship between the severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia (PE). Design: Prospective cohort study conducted in Gauteng, South Africaover...
2.
Dreyer G, Visser C, Dreyer G, Botha M, van der Merwe F, Richter K, et al.
Infect Agent Cancer . 2024 May; 19(1):22. PMID: 38725062
Background: Cervical cancer screening strategies should ideally be informed by population-specific data. Strategies recommended for secondary prevention, are often inadequately studied in populations with high cervical disease burdens. This report...
3.
Botha M, van der Merwe F, Snyman L, Dreyer G, Visser C, Dreyer G
J Low Genit Tract Dis . 2023 Apr; 27(3):212-216. PMID: 37097217
Objective: Screening with primary human papillomavirus (HPV) testing has been evaluated in highly prescreened populations with lower HPV and HIV prevalence than what is the case in South Africa. High...
4.
Vink F, Meijer C, Lissenberg-Witte B, Visser C, Duin S, Snyman L, et al.
Clin Infect Dis . 2022 Nov; 76(3):416-423. PMID: 36366827
Background: Compared with women who are human immunodeficiency virus (HIV) negative, women with human immunodeficiency virus (WWH) have a higher human papillomavirus (HPV) prevalence and increased cervical cancer risk, emphasizing...
5.
Dreyer G, Botha M, Snyman L, Visser C, Burden R, Laubscher N, et al.
Int J Gynecol Cancer . 2022 Jan; 32(5):592-598. PMID: 35078829
Objective: The platform provided by human papillomavirus (HPV) vaccination for linked public health interventions to improve cervical cancer prevention remains incompletely explored. The Vaccine And Cervical Cancer Screen (VACCS) cross-sectional...
6.
Borcinova M, Ragosch V, Jarkovsky J, Bajsova S, Pilka R, Glickman A, et al.
Gynecol Oncol . 2021 Nov; 164(1):76-84. PMID: 34763939
Background: Lower limb lymphoedema (LLL) is the most disabling adverse effect of surgical staging of pelvic lymph nodes. However, the lack of standardisation of volumetric LLL assessment hinders direct comparison...
7.
Cibula D, Kocian R, Plaikner A, Jarkovsky J, Klat J, Zapardiel I, et al.
Eur J Cancer . 2020 Aug; 137:69-80. PMID: 32750501
Background: SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multicentre, prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic lymph node dissection in patients with early-stage cervical cancer. We report the...
8.
Gris J, Aoun J, Rzaguliyeva L, Begum R, Salah H, Tugushi T, et al.
TH Open . 2019 Jun; 2(2):e116-e130. PMID: 31249935
The clinical burden of obstetric venous thromboembolism (VTE) risk is inadequately established. This study assessed the prevalence and management of VTE risk during pregnancy and postpartum outside the Western world....
9.
Dreyer G, van der Merwe F, Botha M, Snyman L, Constant D, Visser C, et al.
S Afr Med J . 2015 Dec; 105(11):912-6. PMID: 26632317
Background: Poor knowledge about cervical cancer plays a role in limiting screening uptake. HPV vaccination provides an untested platform to distribute information that could possibly improve knowledge and screening coverage....
10.
Snyman L, Dreyer G, Botha M, Van der Merwe F, Becker P
S Afr Med J . 2015 Aug; 105(2):115-20. PMID: 26242529
Background: Cervical cancer is preventable, but still highly prevalent in South Africa (SA). Screening strategies in the country have been ineffective, and new ways to prevent the disease are needed....